Statement Of Financial Position [Abstract]
| Concept |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Statement of financial position [abstract] | |||||||||||||||||||||||||||
| Assets [abstract] | |||||||||||||||||||||||||||
| Non-current assets [abstract] | |||||||||||||||||||||||||||
| Property, plant and equipment | — |
93,711,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
92,053,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Right-of-use assets | — |
48,322,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
47,204,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investments accounted for using equity method | — |
57,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
57,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Non-current biological assets | — |
10,515,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
9,993,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Trade and other non-current receivables | — |
518,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
449,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax assets | — |
2,919,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
2,089,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Non-current assets | — |
161,285,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
155,330,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets [abstract] | |||||||||||||||||||||||||||
| Current inventories | — |
35,241,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
24,096,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Trade and other current receivables | — |
7,832,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
6,539,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current biological assets | — |
19,883,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
19,398,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash and cash equivalents | — |
3,337,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
2,446,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — |
2,541,000
EUR
|
| Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners | — |
70,133,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
56,834,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Non-current assets or disposal groups classified as held for sale or as held for distribution to owners | — |
-
EUR
|
— | — | — | — | — | — | — | — | — | — |
315,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | — |
70,133,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
57,149,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Assets | — |
231,418,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
212,479,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Equity and liabilities [abstract] | |||||||||||||||||||||||||||
| Equity [abstract] | |||||||||||||||||||||||||||
| Issued capital | — |
66,617,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
65,951,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | — |
14,654,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
9,329,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share premium | — |
6,707,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
6,707,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Equity attributable to owners of parent | — |
77,105,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
78,622,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Non-controlling interests | — |
428,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
358,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Equity |
2,041,000
EUR
|
77,533,000
EUR
|
13,565,000
EUR
|
428,000
EUR
|
6,707,000
EUR
|
2,829,000
EUR
|
14,654,000
EUR
|
66,617,000
EUR
|
77,105,000
EUR
|
2,041,000
EUR
|
10,251,000
EUR
|
9,328,000
EUR
|
78,980,000
EUR
|
78,623,000
EUR
|
6,707,000
EUR
|
3,002,000
EUR
|
358,000
EUR
|
65,951,000
EUR
|
1,834,000
EUR
|
366,000
EUR
|
9,213,000
EUR
|
6,237,000
EUR
|
92,450,000
EUR
|
65,951,000
EUR
|
6,707,000
EUR
|
2,509,000
EUR
|
92,816,000
EUR
|
| Liabilities [abstract] | |||||||||||||||||||||||||||
| Non-current liabilities [abstract] | |||||||||||||||||||||||||||
| Deferred tax liabilities | — |
1,863,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
1,553,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Non-current liabilities | — |
83,236,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
88,414,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current liabilities [abstract] | |||||||||||||||||||||||||||
| Trade and other current payables | — |
25,352,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
19,482,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current liabilities | — |
70,649,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
45,085,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities | — |
153,885,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
133,499,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Equity and liabilities | — |
231,418,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
212,479,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |